Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Proof of Concept Trial of BCX9930 in Renal Complement-Mediated Diseases

Trial Profile

A Proof of Concept Trial of BCX9930 in Renal Complement-Mediated Diseases

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BCX 9930 (Primary)
  • Indications Immunological disorders; Kidney disorders
  • Focus Proof of concept; Therapeutic Use
  • Sponsors BioCryst Pharmaceuticals
  • Most Recent Events

    • 30 Mar 2021 New trial record
    • 22 Mar 2021 According to a BioCryst Pharmaceuticals media release, based on recent results, and recent interactions with U.S. and European regulators, the company plans to advance BCX-9930 directly into this proof of concept trial in renal complement-mediated diseases in the second half of 2021.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top